![Office of New Drugs Research Program report cover](https://public4.pagefreezer.com:443/content/FDA/09-03-2023T12:04/https://www.fda.gov/files/styles/medium_3/public/OND_ExtramuralResearchOutcomesReport_1600x900_230302.png?itok=mIc3ph5D)
Office of New Drugs releases two new Fiscal Year 2021 reports
March 3 - Reports summarize extramural research and ORISE fellowship outcomes
March 3 - Reports summarize extramural research and ORISE fellowship outcomes
March 2 - Highlights safety efforts taken to help promote and protect public health
March 2 - Goals are to spur competition, address false and misleading information
March 1 - Highlights OGD’s drug approval efforts, COVID-19 work and more
Feb 28 - Drug approvals, ARC Program offer support for patients with rare diseases
Feb 24 - Webinar will highlight major changes from the 2001 guidance
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.